Galderma Group AG (1GALD)
MTA
Real-time Data
07:00 AM
Day's Range
186.0052 wk Range
140.00Overview - 1GALD - Galderma Group AG
Key Statistics
Valuation
Enterprise Value
36.86B
P/E (Trailing)
‪56.73‬
Price / Sales (TTM)
‪6.96‬
Price / Book
‪5.87‬
EV / EBITDA
‪31.13‬
Profitability
Profit Margin
‪14.57%‬
Operating Margin
‪20.23%‬
Return on Assets
‪5.35%‬
Return on Equity
‪10.82%‬
Ownership
Shares Outstanding
234.56M
Float
131.26M
Held by Insiders
‪21.02%‬
Held by Institutions
‪48.21%‬
Price stats
Beta
‪-0.09‬
50-Day Avg
‪186.40‬
200-Day Avg
‪173.71‬
Dividends
Payout Ratio
‪12.11%‬
Market Cap - 1GALD - Galderma Group AG
Peers - 1GALD - Galderma Group AG
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on MTA.
- 1GALDMTAGalderma Group AG41.32BMarket Cap+22.58%52-week change55.38P/E (Trailing)‪14.57%‬Profit Margin
- 1MRKMTAMerck KGaA55.65BMarket Cap+20.17%52-week change23.47P/E (Trailing)‪11.21%‬Profit Margin
- 1ZTSMTAZoetis Inc.48.46BMarket Cap-106.01%52-week change12.02P/E (Trailing)‪27.68%‬Profit Margin
- 1NBIXMTANeurocrine Biosciences Inc.12.55BMarket Cap+19.30%52-week change22.23P/E (Trailing)‪20.91%‬Profit Margin
- 1VTRSMTAViatris Inc.12.51BMarket Cap+36.15%52-week change-4.70P/E (Trailing)‪-2.78%‬Profit Margin
- 1SOBIMTASwedish Orphan Biovitrum AB10.24BMarket Cap+38.32%52-week change118.86P/E (Trailing)‪4.51%‬Profit Margin
- 1LNTHMTALantheus Holdings, Inc.3.88BMarket Cap+46.67%52-week change24.44P/E (Trailing)‪17.69%‬Profit Margin
Profile Summary - 1GALD - Galderma Group AG
About
Galderma Group AG is a Swiss healthcare company specializing exclusively in dermatology, headquartered in Zug and founded in 1981. The company focuses on skin health through three integrated business segments: injectable aesthetics, dermatological skincare, and therapeutic dermatology. In injectable aesthetics,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
